These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 25317462)
1. The lung microbiome in idiopathic pulmonary fibrosis. What does it mean and what should we do about it? Morris A; Gibson K; Collman RG Am J Respir Crit Care Med; 2014 Oct; 190(8):850-2. PubMed ID: 25317462 [No Abstract] [Full Text] [Related]
2. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis. Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484 [TBL] [Abstract][Full Text] [Related]
3. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687 [TBL] [Abstract][Full Text] [Related]
4. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747 [No Abstract] [Full Text] [Related]
6. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients. Tong X; Su F; Xu X; Xu H; Yang T; Xu Q; Dai H; Huang K; Zou L; Zhang W; Pei S; Xiao F; Li Y; Wang C Front Cell Infect Microbiol; 2019; 9():149. PubMed ID: 31165050 [TBL] [Abstract][Full Text] [Related]
7. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis. Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277 [TBL] [Abstract][Full Text] [Related]
16. The microbiome in IPF: tissue is not the issue. Molyneaux PL Thorax; 2021 Mar; 76(3):218. PubMed ID: 33593961 [No Abstract] [Full Text] [Related]
17. Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis. Dickson RP; Huffnagle GB; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Moore BB; O'Dwyer DN Am J Respir Crit Care Med; 2019 Dec; 200(12):1544-1547. PubMed ID: 31419390 [No Abstract] [Full Text] [Related]
18. Utility of Conventional Culture and MALDI-TOF MS for Identification of Microbial Communities in Bronchoalveolar Lavage Fluid in Comparison with the GS Junior Next Generation Sequencing System. Sung JY; Hwang Y; Shin MH; Park MS; Lee SH; Yong D; Lee K Ann Lab Med; 2018 Mar; 38(2):110-118. PubMed ID: 29214754 [TBL] [Abstract][Full Text] [Related]
19. Persistent Legionnaires' Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms. Pérez-Cobas AE; Ginevra C; Rusniok C; Jarraud S; Buchrieser C mBio; 2020 May; 11(3):. PubMed ID: 32430469 [TBL] [Abstract][Full Text] [Related]
20. Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise. Twigg HL; Morris A; Ghedin E; Curtis JL; Huffnagle GB; Crothers K; Campbell TB; Flores SC; Fontenot AP; Beck JM; Huang L; Lynch S; Knox KS; Weinstock G; Lancet Respir Med; 2013 Jul; 1(5):354-6. PubMed ID: 24429191 [No Abstract] [Full Text] [Related] [Next] [New Search]